| Variable |
n (%) |
P-value* |
| Fever |
|
| Yes |
21(70.0) |
0.043 |
| No |
9(30.0) |
| Weight loss |
|
| Yes |
30(100.0) |
- |
| No |
0(0.0) |
| Skin lesions |
|
| Yes |
25(83.3) |
0.000 |
| No |
5(16.7) |
| Splenomegaly |
|
| Yes |
28(93.3) |
0.000 |
| No |
2(6.7) |
| Hepatomegaly |
|
| Yes |
21(70.0) |
0.043 |
| No |
9 (30.00 |
| Active bleeding of the digestive tract mucosae |
|
| Yes |
7(23.3) |
0.005 |
| No |
23(66.7) |
| Jaundice |
|
| Yes |
6(20.0) |
0.001 |
| No |
22(80.0) |
| Pale skin and mucosae |
|
| Yes |
21(70.0) |
0.043 |
| No |
9(30.0) |
| Weakness and myalgia |
|
| Yes |
23(76.7) |
0.005 |
| No |
7(23.3) |
| Diarrhea |
| Yes |
26(86.7) |
0.000 |
| No |
4(13.3) |
| Fluids in visceral cavities |
| No |
20(66.7) |
0.099 |
| Yes |
10(33.3) |
|
| *χ2 test.
Categorial variables are reported as n (%) |
| Table 4: Clinical manifestations in 30 renal transplant recipients with posttransplantation
Visceral Leishmaniasis. |
